Treatment of complicated colorectal cancer. Evaluation of the outcome

被引:2
|
作者
Saliangas K. [1 ,2 ]
Economou A. [1 ]
Nikoloudis N. [1 ]
Andreadis E. [1 ]
Prodromou K. [1 ]
Chrissidou M. [1 ]
Topsis D. [1 ]
Chrissidis T. [1 ]
机构
[1] Department of Surgery, General Hospital of Edessa
[2] Veria 59100
关键词
Bleeding; Complicated colorectal cancer; Obstruction; Perforation;
D O I
10.1007/s10151-004-0156-3
中图分类号
学科分类号
摘要
A comparison of the outcome of 66 patients with complicated colorectal cancer (CRC) who underwent an emergency operation and 217 electively operated patients in an 11-year period was retrospectively determined. The complications presented on admission were obstruction (13.4%), perforation with peritonitis (6.36%), obstruction and perforation (1.4%) and massive bleeding (2.1%). The majority of the patients electively treated were of stages II and III (45.5% and 29%) and those urgently operated on were stages III and IV (67.7% and 14.1%) respectively. Radical resections were performed in 45 patients and palliative in 21. Only ten patients from the urgently treated are still alive and free of the disease. In conclusion, the treatment of complicated CRC carries a considerable incidence of complications, morbidity and mortality, and the overall 5-year survival rate is disappointing compared to electively treated patients.
引用
收藏
页码:S199 / S201
页数:2
相关论文
共 50 条
  • [1] Emergency treatment of complicated colorectal cancer
    Tebala, Giovanni Domenico
    Natili, Andrea
    Gallucci, Antonio
    Brachini, Gioia
    Khan, Abdul Qayyum
    Tebala, Domenico
    Mingoli, Andrea
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 827 - 838
  • [2] The combined treatment of complicated colorectal cancer
    Chelekhov, AVAV
    Dvornichenko, VVVV
    Minakin, NINI
    Belonogov, AVAV
    Rasulov, RIRI
    Plenkin, SMSM
    ANNALS OF ONCOLOGY, 2006, 17
  • [3] Oral adyuvant treatment for colorectal cancer.
    Ledro-Cano, D
    Ledro-Molina, D
    Brasero-Asencio, JL
    Herrerias, JM
    Herrerias, JM
    GASTROENTEROLOGY, 2000, 118 (04) : A1396 - A1396
  • [4] Treatment strategy for obstructive colorectal cancer.
    Iwagami, Shiro
    Miyanari, Nobutomo
    Kubota, Tatsuo
    Nakao, Yousuke
    Yamao, Takanobu
    Sugihara, Hidetaka
    Sawayama, Hiroshi
    Mizumoto, Takao
    Kitano, Yuuki
    Baba, Hideo
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [5] Capecitabine in the treatment of metastatic colorectal cancer.
    Brockmann, B
    Magacz, A
    Bierig, S
    Kraube, K
    ANNALS OF ONCOLOGY, 2000, 11 : 55 - 55
  • [6] Colorectal cancer. Prophylaxis and secondary treatment
    Eickhoff, A.
    Striegel, J.
    Riemann, J. F.
    GASTROENTEROLOGE, 2007, 2 (05): : 339 - 349
  • [7] Colorectal cancer. Early diagnosis and treatment
    March Noguera, Joan
    MEDICINA BALEAR, 2014, 29 (03): : 65 - 65
  • [8] Variation in the cost of treatment for colorectal cancer.
    Ferro, S. A.
    Cosler, L. E.
    Wolff, D. A.
    Poniewierski, M. S.
    Culakova, E.
    Khorana, A. A.
    Lyman, G. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 176S - 176S
  • [9] POSTOPERATIVE OUTCOME OF POSITIVE PERITONEAL CYTOLOGY IN COLORECTAL CANCER.
    Fujimoto, Y.
    Akiyoshi, T.
    Konishi, T.
    Fukunaga, Y.
    Nagayama, S.
    Ueno, M.
    Muto, T.
    DISEASES OF THE COLON & RECTUM, 2013, 56 (04) : E274 - E274
  • [10] Results of the treatment of colorectal cancer complicated by obstruction
    Stoyanov, H
    Julianov, A
    Valtchev, D
    Matev, A
    WIENER KLINISCHE WOCHENSCHRIFT, 1998, 110 (07) : 262 - 265